Seeking Alpha

Don Dion

 
View as an RSS Feed
View Don Dion's Articles BY TICKER:
AA, AAOI, AAPL, AAVL, ABBV, ABX, ABY, ADPT, AERI, AET, AGN, AGRX, AGTC, AKAO, AKBA, ALCO, ALDR, ALDX, ALJJ, ALLY, AMBR, AMBX, AMC, AMDA, AMPH, AMZN, ANET, APP, AQXP, AR, ARCB, ARES, ARGS, ARGT, ARMK, ARPI, ASPN, ASPS, ASPX, ATEN, ATHM, ATRA, AVH, AZN, AZSEY, BA, BABA, BAC, BBRY, BCRH, BCS, BF.B, BHLB, BLK, BLUE, BNFT, BNK, BNPQY, BOND, BRG, BRK.A, BRK.B, BRX, BTU, BURL, BX, BYDDY, C, CBPX, CBRL, CBSO, CCS, CDW, CDX, CELP, CG, CHGG, CIO, CIT, CLDN, CMCM, CMRX, CNCE, COMM, CORI, COUP, COVS, CPWR, CQB, CQH, CRCM, CRTO, CS, CSLT, CTLT, CTT, CUDA, DADDY, DB, DBA, DBC, DBO, DIS, DLNG, DPRX, DRII, DRNA, DRW, DSG, DSKY, EARS, EBAY, EBIO, ECR, EEM, EGRX, EIGI, ELY, ENTA, EPE, EPP, EROS, ESI, ESNT, ESRT, EUM, EVDY, EVGN, EVHC, EWA, EWM, F, FB, FCB, FDO, FELP, FEYE, FFWM, FIVN, FLXN, FMI, FPI, FRM, FRSH, FUEL, FWM, GDOT, GE, GFIS, GILD, GLD, GLOB, GLOP, GLYC, GM, GNCA, GOGO, GOMO, GOOG, GOOGL, GPRK, GPRO, GPS, GRN, GRUB, GS, GSG, HELI, HGG, HIVE, HLF, HLT, HMHC, HMLP, HPQ, HQY, HRTG, HSY, IAU, IBP, ICC, ICD, IEP, IMDZ, IMPR, IMS, INGN, INNL, INP, INTC, ISTR, IVZ, JBLU, JD, JGW, JMEI, JNJ, JPM, KANG, KIN, KING, KITE, KKR, KMI, KNMD, KPTI, KTWO, LADR, LDRH, LEJU, LGIH, LMNS, LNTH, LNVGF, LOCO, LPG, LQ, LULU, MAT, MBII, MBLY, MBUU, MC, MDWD, MGNX, MIK, MMI, MOBL, MODN, MONT, MRD, MRIN, MRK, MRKT, MS, MSFT, MTLS, MVNR, MYCC, NADL, NAO, NCFT, NEP, NERV, NFLX, NMBL, NORD, NSANF, NSANY, NVGS, NWHM, OCIP, OCIR, OCUL, OEC, OPWR, OUTR, OXFD, PAGP, PARN, PAYC, PBFX, PBPB, PCTY, PE, PEGI, PEP, PFE, PG, PIH, PINC, PNC, PSJ, QIWI, QTNT, QTS, QTWO, QUNR, QURE, RARE, RBA, REPH, RICE, RIGP, RLYP, RMAX, RNG, RP, RSPP, RSX, RUBI, RVNC, RYI, SABR, SBUX, SC, SCAI, SCPB, SCYX, SEMI, SERV, SFXE, SLV, SMLR, SNDE, SNE, SNOW, SPKE, SPWH, SQBK, SRLP, SRVA, SSNI, SSNLF, STAY, STBFY, STI, STST, SYF, T, TCPI, TCS, TEDU, TERP, TGT, THD, THNX, TLMR, TLOG, TMHC, TNDM, TNET, TOUR, TPRE, TRIV, TRUE, TRUP, TSE, TSLA, TSQ, TTOO, TWOU, TWTR, UBS, VBLX, VCSH, VCYT, VEEV, VJET, VLP, VMEM, VNCE, VNM, VNOM, VOD, VRNS, VSAR, VTL, VTTI, WB, WBAI, WFC, WFM, WIX, WLKP, WMS, WMT, WNRL, WSTC, WUBA, XENT, XNCR, XNET, XOM, YHOO, ZEN, ZPIN, ZSPH, ZU
  • Investors Should Dig Deep For North American Offshore's IPO Quiet Period Expiration
    Mon, Jun. 30 NAO Comment!

    Summary

    • The 25 day quiet period on underwriter research on NAO, initiated by the firm's June 11 IPO, will come to an end on July 7.
    • NAO had a less than impressive IPO but has seen steady gains since; underwriters will likely try to boost the stock further with their detailed positive reports on July 8.
    • We see this event as a solid short-term buying opportunity for aggressive investors .
  • Amazon's Fire Phone Douses Shareholders' Expectations
    Mon, Jun. 30 AAPL, BABA, AMZN 28 Comments

    Summary

    • So far, there is no indication that Amazon's Fire Phone can compete against Apple's iPhone.
    • Amazon has a pattern of trying to diversify from just e-commerce; however, growth is stalling in the meantime.
    • With competitor Alibaba's NYSE IPO looming large, Amazon investors should hope that the company focuses more on its core business to reverse losses in 2014.
  • Gold Is For Fools And 'The Oracle Of Omaha' Warren Buffett Agrees
    Mon, Jun. 30 HRTG, IAU, GLD 60 Comments

    Summary

    • 94.4 billion yuan (~$15 billion) of improper gold-backed loans were uncovered in a recent probe by China’s National Audit Office.
    • Gold prices fell on this news; worries that China may crack down further commodities-backed loans have increased.
    • Given gold’s temperamental history as an investment, along with this negative news, we suggest investors look for better growth prospects.
  • Abengoa Yield PLC IPO Quiet Period End Switches On A Great New Buying Opportunity
    Fri, Jun. 27 ABY 7 Comments

    Summary

    • The SEC-enforced 25-day quiet period on underwriter research reports on ABY will come to an end on July 7, allowing the IPO underwriters to release analyses July 8.
    • ABY was formed by Spanish multinational S.A. Abengoa to manage and acquire revenue-generating assets related to Abengoa's renewable energy and conventional power assets located in the Americas and Spain.
    • ABY has had a strong market performance since its IPO launch; the many solid IPO underwriters could boost the share price with positive detailed research reports.
  • Memorial Resource Development IPO Expiration Provides Hot Buying Opportunity
    Thu, Jun. 26 MRD 3 Comments

    Summary

    • The quiet period expiration for MRD is July 7; on July 8, MRD's lengthy, impressive list of underwriters will likely attempt to push the stock higher with positive reports.
    • MRD has had a solid market performance post-IPO in the current environment favorable to energy IPOs.
    • We see MRD's quiet period expiration as another buying opportunity for an already strong stock.
  • Bain And Blackstone Crafting Michaels Companies IPO
    Thu, Jun. 26 MIK 2 Comments

    Summary

    • MIK is an operator of specialty arts and crafts retail locations in North America, taken private in 2006 by affiliates of Bain Capital and Blackstone.
    • Bain and Blackstone, each of whom will hold approximately 40% of MIK's shares, have helped MIK thrive and grow its online presence.
    • We are positive on the MIK IPO, also given very strong underwriting and being a household brand name.
  • Future Looks Bright For TCP International Holdings IPO
    Wed, Jun. 25 TCPI 2 Comments

    Summary

    • TCPI, a manufacturer of LED and CFL lighting technologies, plans to raise $100.0 million in its upcoming IPO.
    • McKinsey estimates that global markets for LED and CFL lighting will grow from $22.1 billion in 2011 to $87.4 billion in 2020.
    • With a broad customer base and attainment of profitability, we are optimistic on this IPO.
  • Investors Should Get Energized For NextEra Energy Partners IPO
    Wed, Jun. 25 NEP, NEE 5 Comments

    Summary

    • NEP is a limited partnership formed by NextEra Energy, Inc. to acquire, own, and operate clean energy projects.
    • Given the annual yield of 3.75% at the midpoint of the expected IPO price range, we rate this IPO a buy if it prices within or below the expected range.
    • We are also positive on NEP's impressive management team and strong underwriters.
  • Bank Of America May Be Failing Its New York Customers
    Wed, Jun. 25 HRTG, BAC 151 Comments

    Summary

    • The New York Attorney's Office has shown concern over BAC's unnecessarily stringent lending practices to many average Americans with minor violations, such as overdraft fees.
    • BAC's overly stringent regulations may deeply and negatively affect mid to low income families, students with loans, and low income earners.
    • Given BAC's growing history of potentially harming consumers, we suggest shareholders consider selling their BAC stock.
  • Some Nerves Surrounding Minerva Neurosciences IPO
    Wed, Jun. 25 NERV 4 Comments

    Summary

    • NERV is a clinical-stage biopharmaceutical firm seeking to develop and commercialize products for the treatment of central nervous system diseases.
    • NERV has yet to generate revenue, given many product candidates are in early stages of development; even if these do gain regulatory approval, they will face stiff competition.
    • We are neutral on this IPO, as NERV's products are diverse and high demand exists for them; however, commercial is not yet clear at this stage.
  • IPO For ServiceMaster Global Holdings Appears Pest-Free
    Wed, Jun. 25 SERV 8 Comments

    Summary

    • SERV, a provider of building maintenance services for businesses and homes, plans to raise $700.1 million in its upcoming IPO.
    • Private equity firm CD&R has had seven years to improve the firm's fortunes, and we believe it will price the IPO conservatively.
    • We are positive on this IPO; SERV is massive in scale and could benefit from name recognition in its offering.
  • GoPro IPO Set To Launch
    Wed, Jun. 25 GPRO 47 Comments

    Summary

    • GoPro, manufacturer of a popular line of wearable cameras and accessories, plans to raise $400.5 million in its upcoming IPO.
    • GoPro has exhibited impressive revenue growth and consistently improving incomes over the course of the past several years, as well as solid management.
    • We rate this IPO a Buy as we hear the deal is shaping up well.
  • With Many Strong Partners, Ambrx IPO A Buy
    Tue, Jun. 24 AMBX Comment!

    Summary

    • AMBX is a clinical-stage biotechnology firm, seeking to develop bio-conjugate protein therapeutics for the treatment of various diseases.
    • AMBX also is involved in numerous collaborative projects with Merck, Bristol-Myers Squibb, Ely Lily, and other large firms, which has mitigated some financial risk.
    • We are positive on this IPO and suggest biotech investors be so, as well.
  • Rebuild Your Portfolio Around The Materialise NV IPO
    Tue, Jun. 24 MTLS 17 Comments

    Summary

    • MTLS, a provider of 3-D printing services and additive manufacturing software, plans to raise $104.0 million in its upcoming IPO.
    • MTLS believes its software platforms are now the market standard for 3-D printing and boasts a current installed base of more than 8,000 licenses for its software.
    • We strongly suggest growth investors consider buying into this IPO, as the company has also posted strong revenues and has a very impressive overall team.
  • Imprivata IPO Looks Enticing
    Tue, Jun. 24 IMPR 1 Comment

    Summary

    • Imprivata Inc., a provider of authentication and access management software to the healthcare industry, plans to raise $75.0 million in its upcoming IPO.
    • Imprivata believes its primary competitor to be Caradigm USA LLC, a joint venture by Microsoft Corporation and General Electric.
    • We recommend aggressive investors consider this IPO. We are hearing the deal is in excellent shape.
  • Amphastar Pharmaceuticals IPO Could Be A Star Among Biotech Stocks
    Tue, Jun. 24 AMPH 3 Comments

    Summary

    • AMPH is a manufacturer and marketer of “technically-challenging” injectable and inhalation pharmaceuticals.
    • Contrary to many early stage biotech firms AMPH has turned a profit in each of the past three years, although posted a loss in Q1 2014.
    • We are optimistic on this IPO, given its large portfolio of product candidates, commitment to R&D and strong management.
  • IPO For KineMed Does Not Pass The Test
    Tue, Jun. 24 KNMD 1 Comment

    Summary

    • KNMD, developer of a biomarker platform technology, used in medical diagnostics and drug development, plans to raise $31.5 million in its upcoming IPO.
    • KNMD is losing money at an accelerating rate, and is scarcely generating revenue despite many powerful partnerships.
    • We plan to avoid this IPO and suggest investors consider doing so, as well.
  • Adeptus Health IPO May Put You In The Emergency Room
    Tue, Jun. 24 ADPT 2 Comments

    Summary

    • ADPT, an operator of a network of independent, free-standing emergency rooms, plans to raise $100.5 million in its upcoming IPO.
    • ADPT faces competition from other firms offering free-standing emergency rooms, along with traditional emergency care services in hospitals.
    • While the market for ADPT's services and products is large, the firm is losing a lot of money.
  • We Plan To Take A Hard Look At The IPO For Xunlei Ltd
    Tue, Jun. 24 XNET 5 Comments

    Summary

    • XNET, a Chinese provider of a cloud-based internet platform, designed to allow customers to access digital content at higher speeds, plans to raise $73.2 million in its upcoming IPO.
    • While the environment for Chinese tech company IPOs has been positive lately, we have some concerns about XNET's core business could be at risk when China increases its internet speed.
    • We like this IPO.
  • Bank Of America Versus The United States Of America
    Mon, Jun. 23 BNPQY, BAC 163 Comments

    Summary

    • BAC contacted our Federal Attorney Eric Holder to negotiate how BAC will pay billions in penalties for faulty mortgages, leading up to the financial crisis.
    • Whichever way negotiations work out, BAC will be severely hampered going forward in 2014 and beyond, feeling the strain of a $12 billion fine.
    • These financial losses, coupled with mounting cases of dishonest practices in the US and abroad, lead us to suggest shareholders consider selling BAC now.
  • Investors Switch To Netflix In Q2 2014
    Mon, Jun. 23 AAPL, INTC, TSLA 11 Comments

    Summary

    • June has been a strong month for many well-known tech stocks, including NFLX, which posted a 30% gain since the start of May.
    • An apparent shift in investors’ risk tolerance after a tough winter has been a boon for the tech investing environment.
    • With new programming scheduled and a strong fundamental foundation, we are positive on NFLX going into Q3 and the rest of 2014.
  • General Electric Lights Up France And Beyond
    Sun, Jun. 22 ALSMY, GE 27 Comments

    Summary

    • The French government has accepted GE’s $17 billion bid for Alstom if GE agrees that the state will hold a 20 percent stake in Alstom.
    • This represents a victory, for GE is securing France’s approval for a deal that will continue to propel GE’s global energy leadership in 2014 and beyond.
    • We are optimistic on GE going forward given the company’s strong history and suggest investors be so, as well.
  • Arista Networks' IPO Quiet Period Expiration Opens Another Buying Opportunity For A Successful Stock
    Fri, Jun. 20 ANET 4 Comments

    Summary

    • The 25-day quiet period on underwriters research that began with ANET's June 5 IPO will come to an end on July 1.
    • ANET has seen steady growth since its IPO and strong clients.
    • ANET's quiet period offers another buying opportunity for a strong, promising stock.
  • General Motors' 2014 Nightmare Continues; Investors Shouldn't Wait For Company To Wake Up
    Thu, Jun. 19 F, NSANY, TM 33 Comments

    Summary

    • GM announced the recall of another 3.4 million vehicles for ignition switch problems.
    • Nightmare continues for GM, mired in negative press, and costly recalls.
    • While GM has made some positive moves abroad, until it can clean up its act internally, the stock price will not likely recover.
  • Tesla Powers Up In The U.K. And China: Future Looks Bright
    Thu, Jun. 19 TSLA 77 Comments

    Summary

    • Tesla announced plans to construct a manufacturing plant in Europe; European sales reached 3,467 units within the first 120 days.
    • In 2013, sales skyrocketed and net losses narrowed significantly, showing a more established status.
    • We are increasingly positive on Tesla as the company's growth strategy begins to play out on a global scale.
  • Apple, Starbucks, Fiat Caught In EU State Aid Investigation
    Wed, Jun. 18 FIATY, SBUX, SSNLF 16 Comments

    Summary

    • The European Commission charged Apple with failure to pay required taxes; the US Senate found Apple paid a 2% tax rate with Irish taxing authorities (top rate of 12.5%).
    • Apple is facing increased competition in the UK, EU and beyond in TV and music streaming, wearables, smart home systems, and hardware devices.
    • Despite these negative points, we are confident Apple will continue to be a solid holding in 2014.
  • Eclipse Resources IPO Could Outshine Competition
    Wed, Jun. 18 ECR 8 Comments

    Summary

    • ECR is an independent oil and natural gas E&P firm operating in the Appalachian Basin, with approximately 227,239 net acres in Eastern Ohio.
    • ECR has many competitors in its vicinity, yet boasts a significant drilling inventory and potentially highly productive acreage, which it still has to exploit.
    • Given the market's strong reception to E&Ps lately, we suggest investors consider buying into this IPO.
  • Intel Is A Buy For 2014
    Wed, Jun. 18 INTC 16 Comments

    Summary

    • Intel's revenue outlook has been raised by ~$1billion, following new, favorable industry changes.
    • Intel stock increased over 6% on the news that Microsoft is shifting operating systems, opening new demand; Intel has also shown strong profit margins.
    • We are positive on Intel stock moving forward in 2014.
  • IPO For Kite Pharma Might Fly High
    Wed, Jun. 18 KITE 6 Comments

    Summary

    • KITE is a clinical-stage biopharmaceutical firm pursuing novel cancer immunotherapy products.
    • KITE boasts highly qualified management; in addition to strong business experience, its president and CEO is director of the Institute of Urologic Oncology at the UCLA medical school.
    • We suggest aggressive investors consider this IPO, but competition is strong and KITE has yet to come close to commercializing its products.
  • ZS Pharma IPO Could Cause (Instead Of Soothe) Investor Pain
    Tue, Jun. 17 RLYP, ZSPH 11 Comments

    Summary

    • ZSPH is a biopharmaceutical firm, focused on the development and commercialization of treatments for hyperkalemia and various other diseases.
    • ZSPH competes with firms with far greater marketing resources; although lead product ZS-9 is close FDA filing, there is no guarantee it will be approved or gain traction.
    • We suggest investors hold off on this IPO.
  • IPO Of Viper Energy Partners Will Not Sting You
    Tue, Jun. 17 FANG, VNOM 5 Comments

    Summary

    • VNOM is an oil and gas E&P, formed by Diamondback Energy to acquire and exploit resources in North America.
    • Diamondback will own and control VNOM's general partner, which in turn will hold some 93% of VNOM's common units.
    • We suggest investors buy this energy IPO.
  • Investors Should Avoid Parnell Pharmaceuticals IPO
    Tue, Jun. 17 PARN 4 Comments

    Summary

    • Australia-based PARN is a pharmaceutical firm, seeking to develop, manufacture and commercialize animal health products.
    • Although PARN has products marketed in fourteen countries, the firm is losing money and faces strong competition from larger firms.
    • We recommend investors avoid this IPO.